We are live on ! Find out more
CBPO

China Biologic Products Holdings, Inc.
CBPO

Delisted

CBPO was delisted on the 20th of April, 2021.

Back to rankings

86 hedge funds and large institutions have $1.48B invested in China Biologic Products Holdings, Inc. in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

2% more capital invested

Capital invested by funds: $1.45B → $1.48B (+$24.6M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 93 → 86 (-7)

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

67% less call options, than puts

Call options by funds: $2.42M | Put options by funds: $7.32M

Holders
86
Holders Change
-7
Holders Change %
-7.53%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
30
Reduced
26
Closed
17
Calls
$2.42M
Puts
$7.32M
Net Calls
-$4.89M
Net Calls Change
+$824K

Top Buyers

Rank Fund Capital Flow
1
VAM
Vontobel Asset Management
New York
+$63.5M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$56.2M
3
Bank of America
Bank of America
North Carolina
+$43.2M
4
CS
Credit Suisse
Switzerland
+$41.4M
5
BlackRock
BlackRock
New York
+$20M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$75.7M
2
Artisan Partners
Artisan Partners
Wisconsin
-$45.2M
3
ICP
Indus Capital Partners
New York
-$26M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$22.8M
5
Fidelity International
Fidelity International
Bermuda
-$22.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
76
US Bancorp
Minnesota
$15K -$1.54K -19 -9%
Daiwa Securities Group
77
Daiwa Securities Group
Japan
$12K +$12.4K +153 New
AG
78
Advisor Group
Arizona
$11K +$1.54K +19 +15%
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$11K +$11.3K +140 New
Citigroup
80
Citigroup
New York
$10K -$60.5K -749 -86%
IA
81
IFP Advisors
Florida
$9K – – –
Manulife (Manufacturers Life Insurance)
82
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9K – – –
Wells Fargo
83
Wells Fargo
California
$4K – – –
ICP
84
Indus Capital Partners
New York
– -$26M -330,339 Closed
MWNA
85
Marshall Wace North America
New York
– -$8.51M -108,020 Closed
CI
86
Cooper Investors
Australia
– -$4.13M -52,484 Closed
Two Sigma Investments
87
Two Sigma Investments
New York
– -$3.52M -44,704 Closed
Millennium Management
88
Millennium Management
New York
– -$2.61M -33,176 Closed
First Trust Advisors
89
First Trust Advisors
Illinois
– -$2.38M -30,251 Closed
OAM
90
Oxford Asset Management
United Kingdom
– -$1.77M -22,419 Closed
Ohio Public Employees Retirement System (OPERS)
91
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$1.2M -15,177 Closed
AA
92
Antipodean Advisors
New York
– -$1.18M -15,000 Closed
LCM
93
Landscape Capital Management
New Jersey
– -$571K -7,254 Closed
CSS
94
Cubist Systematic Strategies
Connecticut
– -$437K -5,549 Closed
SAM
95
Southeastern Asset Management
Tennessee
– -$287K -3,645 Closed
Lazard Asset Management
96
Lazard Asset Management
New York
– -$126K -1,600 Closed
SG Americas Securities
97
SG Americas Securities
New York
– -$117K -1,482 Closed
GBT
98
Grove Bank & Trust
Florida
– -$9K -116 Closed
FGAM
99
Financial Gravity Asset Management
Texas
– +$81 +1 New
Simplex Trading
100
Simplex Trading
Illinois
– +$162 +2 New
1 2 3
4

CBPO Hedge Fund Activity: Q1 2018 in Review

86 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q1 2018, worth a combined $1.48B — up 1.7% from $1.45B a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CBPO and 12 opened new positions — a net loss of 5 holders — while 26 trimmed existing stakes and 30 added.

The largest buyer was Vontobel Asset Management, adding an estimated $63.5M. The largest seller was Invesco, cutting an estimated $75.7M.

  • 86 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q1 2018, down from 93 in Q4 2017.
  • Funds reported $1.48B of China Biologic Products Holdings, Inc. stock for Q1 2018, up 1.7% quarter-over-quarter.
  • 12 funds opened new China Biologic Products Holdings, Inc. positions in Q1 2018 and 17 closed out, a net change of -5 holders.
  • The largest China Biologic Products Holdings, Inc. buyer in Q1 2018 was Vontobel Asset Management, an estimated $63.5M added.
  • The largest China Biologic Products Holdings, Inc. seller in Q1 2018 was Invesco, an estimated $75.7M sold.

Based on aggregated 13F filings for Q1 2018.